ODT: the challenge of change

Many pharmacies have concerns about the viability of opioid dependence therapies as a result of the recent changes at short notice, Jarrod McMaugh tells the AJP Podcast Victorian branch manager for the Pharmaceutical Society, and its subject expert on harm reduction and opioid dependence therapy, Jarrod McMaugh speaks to AJP Podcast host Carlene McMaugh about

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous 'Tumultuous times for the profession'
Next Strengthening the GP pharmacist role